DK2824114T3 - Farmaceutisk sammensætning til behandling af cancer - Google Patents
Farmaceutisk sammensætning til behandling af cancer Download PDFInfo
- Publication number
- DK2824114T3 DK2824114T3 DK13751164.8T DK13751164T DK2824114T3 DK 2824114 T3 DK2824114 T3 DK 2824114T3 DK 13751164 T DK13751164 T DK 13751164T DK 2824114 T3 DK2824114 T3 DK 2824114T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- cancer treatment
- cancer
- treatment
- pharmaceutical
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012035491 | 2012-02-21 | ||
| PCT/JP2013/054345 WO2013125640A1 (ja) | 2012-02-21 | 2013-02-21 | 癌の治療及び／又は予防用医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2824114T3 true DK2824114T3 (da) | 2019-07-29 |
Family
ID=49005817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13751164.8T DK2824114T3 (da) | 2012-02-21 | 2013-02-21 | Farmaceutisk sammensætning til behandling af cancer |
Country Status (17)
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2733492T3 (en) | 2008-08-05 | 2016-04-25 | Toray Industries | Method for detection of cancer |
| JP5691172B2 (ja) | 2008-08-05 | 2015-04-01 | 東レ株式会社 | 癌の治療及び予防用医薬組成物 |
| KR101805520B1 (ko) * | 2010-02-04 | 2017-12-07 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| PL2740489T3 (pl) * | 2011-08-04 | 2017-06-30 | Toray Industries, Inc. | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka trzustki |
| RU2624040C2 (ru) | 2011-08-04 | 2017-06-30 | Торэй Индастриз, Инк. | Способ обнаружения рака поджелудочной железы |
| HUE034736T2 (en) | 2012-02-21 | 2018-02-28 | Toray Industries | A pharmaceutical composition for the treatment and / or prevention of cancer |
| MX357965B (es) | 2012-03-30 | 2018-08-01 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar. |
| CA2869120C (en) * | 2012-03-30 | 2023-05-23 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of liver cancer |
| KR102056137B1 (ko) | 2012-07-19 | 2019-12-16 | 도레이 카부시키가이샤 | 암의 검출 방법 |
| DK2876446T3 (en) | 2012-07-19 | 2019-03-11 | Toray Industries | Method for detecting cancer |
| PL3031826T3 (pl) | 2013-08-09 | 2019-03-29 | Toray Industries, Inc. | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi |
| KR102726248B1 (ko) | 2016-07-07 | 2024-11-05 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 항체-애쥬번트 접합체 |
| CN109890417A (zh) | 2016-10-28 | 2019-06-14 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
| JP7342701B2 (ja) | 2018-03-30 | 2023-09-12 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| CA3130794A1 (en) | 2019-03-15 | 2020-09-24 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| JP2022537158A (ja) | 2019-06-13 | 2022-08-24 | ボルト バイオセラピューティクス、インコーポレーテッド | アミノベンズアゼピン化合物、イムノコンジュゲート、及びそれらの使用 |
| MX2022003740A (es) | 2019-09-30 | 2022-05-02 | Bolt Biotherapeutics Inc | Inmunoconjugados de aminobenzazepina unidos a amida y usos de estos. |
| KR20220088901A (ko) | 2019-10-25 | 2022-06-28 | 볼트 바이오테라퓨틱스 인코퍼레이티드 | 티에노아제핀 면역접합체, 및 이의 용도 |
| BR112022018161A2 (pt) | 2020-03-12 | 2022-10-25 | Toray Industries | Medicamento para o tratamento e/ou prevenção do câncer, agentes que aumentam a eficácia de um fármaco e método para o tratamento e/ou prevenção do câncer |
| US20230139178A1 (en) | 2020-03-12 | 2023-05-04 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| KR20220152318A (ko) | 2020-03-12 | 2022-11-15 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
| BR112022018171A2 (pt) | 2020-03-12 | 2022-10-25 | Toray Industries | Medicamento para o tratamento e/ou a prevenção de câncer, agentes aumentando a eficácia de droga de uma composição farmacêutica e método para tratar e/ou prevenir câncer |
| BR112022018166A2 (pt) | 2020-03-12 | 2022-10-25 | Toray Industries | Medicamento para tratamento e/ou prevenção de câncer, agentes que aumentam a eficácia de droga de uma composição farmacêutica e método para tratar e/ou prevenir câncer |
| WO2021226440A1 (en) | 2020-05-08 | 2021-11-11 | Bolt Biotherapeutics, Inc. | Elastase-substrate, peptide linker immunoconjugates, and uses thereof |
| EP4196168A1 (en) | 2020-08-13 | 2023-06-21 | Bolt Biotherapeutics, Inc. | Pyrazoloazepine immunoconjugates, and uses thereof |
| KR20240024074A (ko) | 2021-06-23 | 2024-02-23 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
| KR20240024803A (ko) | 2021-06-23 | 2024-02-26 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
| US20250066502A1 (en) | 2021-07-27 | 2025-02-27 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| AU2022320304A1 (en) | 2021-07-27 | 2024-02-29 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| MX2024001099A (es) | 2021-07-27 | 2024-02-23 | Toray Industries | Medicamento para el tratamiento y/o prevencion de cancer. |
| WO2023033129A1 (ja) | 2021-09-03 | 2023-03-09 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| CA3234604A1 (en) | 2021-10-29 | 2023-05-04 | Shelley Erin ACKERMAN | Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereof |
| JPWO2024005123A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2022-06-30 | 2024-01-04 | ||
| WO2024043252A1 (ja) | 2022-08-24 | 2024-02-29 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| CN119768181A (zh) | 2022-08-24 | 2025-04-04 | 东丽株式会社 | 用于癌的治疗和/或预防的药品 |
| JPWO2024043258A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2022-08-24 | 2024-02-29 | ||
| WO2024048541A1 (ja) | 2022-08-30 | 2024-03-07 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| AU2023334696A1 (en) | 2022-08-30 | 2025-02-27 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| KR20250118852A (ko) | 2022-12-23 | 2025-08-06 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
| WO2024173384A1 (en) | 2023-02-14 | 2024-08-22 | Bolt Biotherapeutics, Inc. | Aza-benzazepine immunoconjugates, and uses thereof |
| WO2024186626A1 (en) | 2023-03-03 | 2024-09-12 | Bolt Biotherapeutics, Inc. | Aza-bicyclic sting agonist immunoconjugates, and uses thereof |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| HU221385B1 (en) | 1994-07-13 | 2002-09-28 | Chugai Pharmaceutical Co Ltd | Reconstituted human antibody against human interleukin-8 |
| US5698396A (en) | 1995-06-07 | 1997-12-16 | Ludwig Institute For Cancer Research | Method for identifying auto-immunoreactive substances from a subject |
| WO2001032910A2 (en) | 1999-10-29 | 2001-05-10 | Human Genome Sciences, Inc. | 27 human secreted proteins |
| FR2761994B1 (fr) | 1997-04-11 | 1999-06-18 | Centre Nat Rech Scient | Preparation de recepteurs membranaires a partir de baculovirus extracellulaires |
| EP2363484A3 (en) | 1998-04-03 | 2012-04-25 | Chugai Seiyaku Kabushiki Kaisha | Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody |
| US20030118599A1 (en) | 1999-04-02 | 2003-06-26 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| RU2234942C2 (ru) | 1998-07-14 | 2004-08-27 | Корикса Корпорейшн | Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид |
| CA2334038A1 (en) | 1998-07-14 | 2000-01-27 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
| US6969518B2 (en) | 1998-12-28 | 2005-11-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6335170B1 (en) | 1999-02-22 | 2002-01-01 | Torben F. Orntoft | Gene expression in bladder tumors |
| JP2002540790A (ja) | 1999-04-02 | 2002-12-03 | コリクサ コーポレイション | 肺癌の治療および診断のための化合物ならびにその使用のための方法 |
| US6444425B1 (en) | 1999-04-02 | 2002-09-03 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
| US6949245B1 (en) | 1999-06-25 | 2005-09-27 | Genentech, Inc. | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| US20020006404A1 (en) | 1999-11-08 | 2002-01-17 | Idec Pharmaceuticals Corporation | Treatment of cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications |
| HUP0500345A2 (hu) | 2000-03-29 | 2005-07-28 | Corixa Corporation | Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására |
| EP1354034B8 (en) | 2000-11-30 | 2008-06-18 | Medarex, Inc. | Transgenic transchromosomal rodents for making human antibodies |
| US7919467B2 (en) | 2000-12-04 | 2011-04-05 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| US20040029114A1 (en) | 2001-01-24 | 2004-02-12 | Eos Technology, Inc. | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| RU2306952C2 (ru) | 2001-01-31 | 2007-09-27 | Байоджен Айдек Инк. | Лечение в-клеточных злокачественных опухолей с использованием комбинации применений, связанных с антителами, уменьшающими количество b-клеток, и с иммуномодулирующими антителами |
| AU2002311787A1 (en) | 2001-03-28 | 2002-10-15 | Zycos Inc. | Translational profiling |
| WO2002083070A2 (en) | 2001-04-10 | 2002-10-24 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| WO2002092812A1 (en) | 2001-05-11 | 2002-11-21 | Kirin Beer Kabushiki Kaisha | ARTIFICIAL HUMAN CHROMOSOME CONTAINING HUMAN ANTIBODY μ LIGHT CHAIN GENE |
| AU2002311909A1 (en) | 2001-05-11 | 2002-11-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US20030190640A1 (en) | 2001-05-31 | 2003-10-09 | Mary Faris | Genes expressed in prostate cancer |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| US20040258678A1 (en) | 2002-02-22 | 2004-12-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US20050003390A1 (en) | 2002-05-17 | 2005-01-06 | Axenovich Sergey A. | Targets for controlling cellular growth and for diagnostic methods |
| CN1681927A (zh) | 2002-07-12 | 2005-10-12 | 加利福尼亚大学董事会 | 改进的转运蛋白及其用途 |
| US20040126379A1 (en) | 2002-08-21 | 2004-07-01 | Boehringer Ingelheim International Gmbh | Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents |
| AU2003302386B2 (en) | 2002-11-26 | 2010-04-01 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| WO2004097051A2 (en) | 2003-04-29 | 2004-11-11 | Wyeth | Methods for diagnosing aml and mds differential gene expression |
| EP2003196A3 (en) | 2003-06-09 | 2009-01-07 | The Regents of the University of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2005007830A2 (en) | 2003-07-14 | 2005-01-27 | Mayo Foundation For Medical Education And Research | Methods and compositions for diagnosis, staging and prognosis of prostate cancer |
| US20050032113A1 (en) | 2003-07-17 | 2005-02-10 | Mitsubishi Pharma Corporation | Membrane protein library for proteome analysis and method for preparing same |
| JP2008506352A (ja) | 2004-01-26 | 2008-03-06 | デビオビジョン・インコーポレーテッド | 新生物特異的ポリペプチド及びその使用 |
| DK1735348T3 (da) | 2004-03-19 | 2012-07-16 | Imclone Llc | Humant anti-epidermalt vækstfaktorreceptorantistof |
| AU2005229457B2 (en) | 2004-03-30 | 2010-11-25 | Glaxo Group Limited | Immunoglobulins |
| WO2005100998A2 (en) | 2004-04-16 | 2005-10-27 | Europroteome Ag | Membrane markers for use in cancer diagnosis and therapy |
| WO2006002378A2 (en) | 2004-06-23 | 2006-01-05 | Avalon Pharmaceuticals | Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| KR20200058588A (ko) | 2005-01-21 | 2020-05-27 | 제넨테크, 인크. | Ｈｅｒ 항체의 고정 용량 투여법 |
| WO2006089212A2 (en) | 2005-02-18 | 2006-08-24 | Children's Medical Center Corporation | Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin |
| KR101310000B1 (ko) | 2005-03-11 | 2013-09-25 | 싸이퍼젠 바이오시스템즈, 인코포레이티드 | 난소암 및 자궁내막암에 대한 바이오마커 : 헵시딘 |
| JP2006316040A (ja) | 2005-05-13 | 2006-11-24 | Genentech Inc | Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法 |
| US8014957B2 (en) | 2005-12-15 | 2011-09-06 | Fred Hutchinson Cancer Research Center | Genes associated with progression and response in chronic myeloid leukemia and uses thereof |
| EP1991701A4 (en) | 2006-02-14 | 2010-03-17 | Dana Farber Cancer Inst Inc | COMPOSITIONS, KITS AND METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CANCER |
| US20100015724A1 (en) | 2006-08-17 | 2010-01-21 | Peter Hornbeck | Lysine acetylation sites |
| US20080107668A1 (en) | 2006-08-30 | 2008-05-08 | Immunotope, Inc. | Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| WO2008031041A2 (en) | 2006-09-07 | 2008-03-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
| WO2008059252A2 (en) | 2006-11-15 | 2008-05-22 | Oxford Biomedica (Uk) Limited | Methods and composition fro t cell receptors which recognize 5t4 antigen |
| JP5663834B2 (ja) | 2008-03-14 | 2015-02-04 | 東ソー株式会社 | 遺伝子組換え抗体の製造方法 |
| KR20180035923A (ko) | 2008-03-18 | 2018-04-06 | 제넨테크, 인크. | 항-ｈｅｒ２ 항체-약물 접합체와 화학요법제의 병용물, 및 사용 방법 |
| DK2733492T3 (en) * | 2008-08-05 | 2016-04-25 | Toray Industries | Method for detection of cancer |
| MX348464B (es) | 2008-08-05 | 2017-06-14 | Toray Industries | Agente inductor de inmunidad. |
| JP5691172B2 (ja) * | 2008-08-05 | 2015-04-01 | 東レ株式会社 | 癌の治療及び予防用医薬組成物 |
| PT2467401T (pt) | 2009-08-19 | 2017-04-26 | Merck Patent Gmbh | Anticorpos para a deteção de complexos de integrina em material ffpe |
| MY160680A (en) | 2009-09-22 | 2017-03-15 | Probiogen Ag | Process for producing molecules containing specialized glycan structures |
| RU2418587C1 (ru) * | 2010-01-21 | 2011-05-20 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО "НижГМА Росздрава") | Способ лечения злокачественных опухолей головного мозга |
| KR101805520B1 (ko) | 2010-02-04 | 2017-12-07 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| PL2532680T3 (pl) | 2010-02-04 | 2015-10-30 | Toray Industries | Kompozycja medyczna do leczenia raka i/lub zapobiegania |
| AU2011211682B2 (en) | 2010-02-04 | 2015-08-13 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| WO2011096528A1 (ja) | 2010-02-04 | 2011-08-11 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| ES2691738T3 (es) | 2010-02-04 | 2018-11-28 | Toray Industries, Inc. | Agente farmacéutico para el tratamiento y/o la prevención de cáncer |
| PL2532366T3 (pl) | 2010-02-04 | 2017-02-28 | Toray Industries, Inc. | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi |
| WO2012005550A2 (ko) | 2010-07-08 | 2012-01-12 | 강원대학교산학협력단 | 담낭암 치료용 약제학적 조성물 및 이를 이용한 담낭암의 성장, 전이 억제 및 치료 방법 |
| SG10201703556YA (en) | 2010-07-26 | 2017-06-29 | Servier Lab | Methods and compositions for liver cancer therapy |
| JP5565183B2 (ja) | 2010-08-06 | 2014-08-06 | 宇部興産株式会社 | フィルムの製造方法 |
| RU2624040C2 (ru) | 2011-08-04 | 2017-06-30 | Торэй Индастриз, Инк. | Способ обнаружения рака поджелудочной железы |
| PL2740489T3 (pl) | 2011-08-04 | 2017-06-30 | Toray Industries, Inc. | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka trzustki |
| CA2844042C (en) * | 2011-08-04 | 2019-06-18 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| MX357965B (es) * | 2012-03-30 | 2018-08-01 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar. |
| CA2869120C (en) * | 2012-03-30 | 2023-05-23 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of liver cancer |
-
2013
- 2013-02-21 CA CA2865020A patent/CA2865020C/en active Active
- 2013-02-21 BR BR112014021103-5A patent/BR112014021103A2/pt not_active Application Discontinuation
- 2013-02-21 RU RU2014138038A patent/RU2633505C2/ru active
- 2013-02-21 WO PCT/JP2013/054345 patent/WO2013125640A1/ja active Application Filing
- 2013-02-21 EP EP13751164.8A patent/EP2824114B1/en active Active
- 2013-02-21 CN CN201380009228.0A patent/CN104114583B/zh active Active
- 2013-02-21 IN IN1716KON2014 patent/IN2014KN01716A/en unknown
- 2013-02-21 MX MX2014009749A patent/MX360211B/es active IP Right Grant
- 2013-02-21 DK DK13751164.8T patent/DK2824114T3/da active
- 2013-02-21 JP JP2013512281A patent/JP6187258B2/ja active Active
- 2013-02-21 KR KR1020147020833A patent/KR102009236B1/ko active Active
- 2013-02-21 HU HUE13751164A patent/HUE045461T2/hu unknown
- 2013-02-21 PT PT13751164T patent/PT2824114T/pt unknown
- 2013-02-21 US US14/379,867 patent/US9266958B2/en active Active
- 2013-02-21 ES ES13751164T patent/ES2739380T3/es active Active
- 2013-02-21 AU AU2013223147A patent/AU2013223147B2/en active Active
- 2013-02-21 PL PL13751164T patent/PL2824114T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014021103A2 (pt) | 2019-10-15 |
| PL2824114T3 (pl) | 2019-11-29 |
| PT2824114T (pt) | 2019-08-05 |
| MX2014009749A (es) | 2014-11-14 |
| BR112014021103A8 (pt) | 2018-01-23 |
| CA2865020C (en) | 2021-01-26 |
| RU2633505C2 (ru) | 2017-10-12 |
| WO2013125640A1 (ja) | 2013-08-29 |
| ES2739380T3 (es) | 2020-01-30 |
| JPWO2013125640A1 (ja) | 2015-07-30 |
| RU2014138038A (ru) | 2016-04-10 |
| JP6187258B2 (ja) | 2017-08-30 |
| MX360211B (es) | 2018-10-24 |
| CA2865020A1 (en) | 2013-08-29 |
| CN104114583B (zh) | 2019-11-19 |
| IN2014KN01716A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-10-23 |
| AU2013223147B2 (en) | 2017-10-05 |
| EP2824114A4 (en) | 2015-10-07 |
| EP2824114A1 (en) | 2015-01-14 |
| HUE045461T2 (hu) | 2019-12-30 |
| KR102009236B1 (ko) | 2019-08-09 |
| EP2824114B1 (en) | 2019-05-22 |
| AU2013223147A1 (en) | 2014-09-11 |
| KR20140130671A (ko) | 2014-11-11 |
| US20150017172A1 (en) | 2015-01-15 |
| CN104114583A (zh) | 2014-10-22 |
| US9266958B2 (en) | 2016-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272206B (en) | Combination therapy for treating cancer | |
| DK2818482T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK2824114T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK3470063T3 (da) | Farmaceutiske sammensætninger til behandling af cftr-medierede sygdomme | |
| DK3181128T3 (da) | Farmaceutisk nilotinib-sammensætning | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| FR2997014B1 (fr) | Composition sterile dermo-injectable | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| PT2854768T (pt) | Composições farmacêuticas de pemetrexed | |
| DK3076976T3 (da) | Fremgangsmåder til behandling af cancer | |
| BR112014028424A2 (pt) | compostos de pirimidina para o tratamento de câncer | |
| BR112014032798A2 (pt) | composição | |
| HUE045314T2 (hu) | Kombinációs terápia rák kezelésére | |
| EP2934454C0 (en) | ANTI-DANDRUFF COMPOSITION | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| DK3511004T3 (da) | Kombineret præparat til behandling af cancer | |
| ES2721400T8 (es) | Composición de Diclofenaco | |
| DK2825558T3 (da) | Kombinationsterapi til behandling af ovariecancer | |
| EP2769718A4 (en) | MEDICAL COMPOSITION | |
| DK3290035T3 (da) | Procaspase-kombinationsterapi til behandling af cancer | |
| DK3052102T3 (da) | Sammensætninger til behandling af cancere | |
| DK2812013T3 (da) | Formulering til behandling af IBS | |
| EP2883547A4 (en) | MEDICINE |